Namwiwat Medical
Namwiwat Medical Corporation Public Company Limited manufactures and distributes medical equipment in Thailand. The company provides medical supplies, disinfection services, medical equipment maintenance services, infectious waste services, and other medical services. It also offers equipment rental and contractual construction services. The company was formerly known as Namwiwat Engineering (199… Read more
Namwiwat Medical (NAM) - Net Assets
Latest net assets as of June 2024: ฿1.95 Billion THB
Based on the latest financial reports, Namwiwat Medical (NAM) has net assets worth ฿1.95 Billion THB as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿2.34 Billion) and total liabilities (฿389.54 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿1.95 Billion |
| % of Total Assets | 83.37% |
| Annual Growth Rate | 96.24% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 53.83 |
Namwiwat Medical - Net Assets Trend (2021–2024)
This chart illustrates how Namwiwat Medical's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Namwiwat Medical (2021–2024)
The table below shows the annual net assets of Namwiwat Medical from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | ฿1.96 Billion | +62.17% |
| 2023-06-30 | ฿1.21 Billion | +178.79% |
| 2022-06-30 | ฿434.12 Million | +67.22% |
| 2021-06-30 | ฿259.61 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Namwiwat Medical's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 52.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ฿118.03 Million | 6.01% |
| Other Components | ฿1.84 Billion | 93.99% |
| Total Equity | ฿1.96 Billion | 100.00% |
Namwiwat Medical Competitors by Market Cap
The table below lists competitors of Namwiwat Medical ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Minrex Resources Ltd
AU:MRR
|
$8.83 Million |
|
TRANSILVANIA BROKER DE ASIGURARE
RO:TBK
|
$8.83 Million |
|
Kalyani Forge Limited
NSE:KALYANIFRG
|
$8.83 Million |
|
EarthRenew Inc
PINK:VVIVF
|
$8.83 Million |
|
ASSETCO PLC LS-01
F:DYJ
|
$8.82 Million |
|
Hsin-Sin Textile Co Ltd
TWO:4406
|
$8.82 Million |
|
Ebusco Holding BV
AS:EBUS
|
$8.82 Million |
|
479880
KQ:479880
|
$8.82 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Namwiwat Medical's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,210,302,137 to 1,962,751,621, a change of 752,449,483 (62.2%).
- Net income of 200,749,511 contributed positively to equity growth.
- Dividend payments of 232,050,000 reduced retained earnings.
- New share issuances of 784,075,330 increased equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿200.75 Million | +10.23% |
| Dividends Paid | ฿232.05 Million | -11.82% |
| Share Issuances | ฿784.08 Million | +39.95% |
| Other Changes | ฿-325.36K | -0.02% |
| Total Change | ฿- | 62.17% |
Book Value vs Market Value Analysis
This analysis compares Namwiwat Medical's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.28x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 9.65x to 1.28x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-06-30 | ฿0.37 | ฿3.58 | x |
| 2022-06-30 | ฿0.62 | ฿3.58 | x |
| 2023-06-30 | ฿1.73 | ฿3.58 | x |
| 2024-06-30 | ฿2.80 | ฿3.58 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Namwiwat Medical utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.23%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 18.24%
- • Asset Turnover: 0.47x
- • Equity Multiplier: 1.20x
- Recent ROE (10.23%) is below the historical average (21.66%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 40.23% | 17.60% | 0.94x | 2.43x | ฿131.24 Million |
| 2023 | 14.52% | 15.98% | 0.65x | 1.40x | ฿54.68 Million |
| 2024 | 10.23% | 18.24% | 0.47x | 1.20x | ฿4.47 Million |
Industry Comparison
This section compares Namwiwat Medical's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $153,312,034
- Average return on equity (ROE) among peers: 62.17%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Namwiwat Medical (NAM) | ฿1.95 Billion | 40.23% | 0.20x | $8.82 Million |
| Business Alignment Public Company Limited (BIZ) | $153.31 Million | 62.17% | 2.02x | $24.47 Million |